Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Exchange Rate Effect (2016 - 2025)

Haemonetics has reported Exchange Rate Effect over the past 17 years, most recently at $810000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at $810000.0 for Q4 2025, up 113.04% from a year ago — trailing twelve months through Dec 2025 was $7.0 million (up 213.53% YoY), and the annual figure for FY2025 was -$685000.0, up 78.49%.
  • Exchange Rate Effect for Q4 2025 was $810000.0 at Haemonetics, up from -$773000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for HAE hit a ceiling of $4.6 million in Q4 2022 and a floor of -$6.2 million in Q4 2024.
  • Median Exchange Rate Effect over the past 5 years was -$720000.0 (2021), compared with a mean of -$423400.0.
  • Peak annual rise in Exchange Rate Effect hit 1053.44% in 2022, while the deepest fall reached 1631.68% in 2022.
  • Haemonetics' Exchange Rate Effect stood at -$667000.0 in 2021, then soared by 784.71% to $4.6 million in 2022, then tumbled by 33.85% to $3.0 million in 2023, then crashed by 305.63% to -$6.2 million in 2024, then skyrocketed by 113.04% to $810000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were $810000.0 (Q4 2025), -$773000.0 (Q3 2025), and $4.2 million (Q2 2025) per Business Quant data.